12 Results for "

human lung carcinoma cell lines

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "human lung carcinoma cell lines" in MCE Product Catalog:

Cat. No.: HY-165245
CAS No.: 625403-59-0
Research Areas:  

Cancer

SBI-183 is an orally active inhibitor of QSOX1 (Kd: 20 μM). SBI-183 suppresses the proliferative and invasive phenotype of renal cancer cell lines, including triple negative breast cancer cell line, lung adenocarcinoma cell line and pancreatic ductal adenocarcinoma. SBI-183 inhibits tumor growth in two human xenograft mouse models of renal cell carcinoma in vivo .
loading...
    loading...
Cat. No.: HY-121352
CAS No.: 934464-79-6
Target:  

Drug Derivative

Research Areas:  

Cancer

Kibdelone C is a hexacyclic tetrahydroxanthone natural product and anticancer agent with sub-nanomolar GI50 activity against human SR leukemia and SN12C renal carcinoma cell lines. Kibdelone C disrupts the actin cytoskeleton in human cancer cells, leading to cell contraction and actin stress fiber formation, without direct actin binding, actin polymerization effects, topoisomerase I/II inhibition, or DNA binding. Kibdelone C can be used for the research of leukemia, and renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-N10363
CAS No.: 162062-88-6
Pixinol, a natural glycoside, shows cytotoxicity against the human lung carcinoma GLC4 and adenocarcinoma COLO 320 cell lines (IC50=71 µM and 43 µM, respectively) .
loading...
    loading...
Cat. No.: HY-181166
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

EGFR-IN-194 is a potent EGFR tyrosine kinase inhibitor with an IC50 of 54.3 nM against human EGFR. EGFR-IN-194 induces apoptosis, inhibits migration in cancer cells, selectively promotes invasion in cancer cells, and exhibits antiproliferative effects across multiple cancer cell lines. EGFR-IN-194 can be used for the research of prostate adenocarcinoma, non-small cell lung carcinoma, breast carcinoma, chronic myeloid leukemia .
loading...
    loading...
Cat. No.: HY-W727102
CAS No.: 180161-92-6
(Z)-8-β-D-Glucopyranosyloxycinnamic acid is a phenolic glycoside present in the roots of Codonopsis javanica. (Z)-8-β-D-Glucopyranosyloxycinnamic acid exhibits no toxicity against lung cancer, liver cancer and breast cancer cell lines .
loading...
    loading...
Cat. No.: HY-118713
CAS No.: 133401-10-2
Kuanoniamine A is a pyridoacridine alkaloid and also an anticancer agent. Kuanoniamine A inhibits DNA synthesis, induces apoptosis, and regulates the cell cycle by reducing the proportion of cells in the G2/M phase. Kuanoniamine A inhibits the proliferation of human lymphocytes. Kuanoniamine A can be used in research related to breast cancer, glioma, non-small cell lung cancer, and melanoma .
loading...
    loading...
Cat. No.: HY-N6052A
CAS No.: 607363-34-8
Synonyms: 3-Hydroxy-9-methoxypterocarpan
(Rac)-Medicarpin (3-Hydroxy-9-methoxypterocarpan) is a pterocarpan isoflavonoid phytoalexin with antimicrobial activity and anti-tumor promoting activity. (Rac)-Medicarpin induces apoptosis in human peripheral blood mononuclear cells. (Rac)-Medicarpin is also a defensive secondary metabolite produced in sword bean calli in response to exposure to spore suspensions of the non-pathogenic fungus Pithomyces chartarum or HgCl2 .
loading...
    loading...
Cat. No.: HY-19896A
CAS No.: 1204956-74-0
COTI-2 hydrochloride is an orally active thiosemicarbazone anticancer agent and p53 mutant activator. COTI-2 hydrochloride induces Apoptosis. COTI-2 hydrochloride triggers the activation of AMPK and the inhibition of the mTOR pathway. COTI-2 hydrochloride induces DNA damage and replication stress responses. COTI-2 hydrochloride binds to misfolded mutant p53 proteins, thereby inducing conformational changes that restore p53 to its normal state and reactivate its function. COTI-2 hydrochloride acts on a variety of cancer cell lines and xenografts. COTI-2 hydrochloride can be used in research related to colorectal cancer, small cell lung cancer, glioblastoma, breast cancer, and ovarian cancer .
loading...
    loading...
Cat. No.: HY-182071
CAS No.: 2349329-01-5
Research Areas:  

Cancer

MG16 is a prodrug of 10-Methoxycamptothecin (HY-N0446). MG16 downregulates CDK6 and upregulates ASK1. MG16 induces cell cycle arrest and Apoptosis. MG16 exhibits anticancer activity against Lewis lung carcinoma, small cell lung cancer, and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-181947
Research Areas:  

Cancer

IDO1-IN-33 (Compound YC-16) is a IDO1 inhibitor (with an IC50 of 0.18 μM for IDO1 in HeLa cells). IDO1-IN-33 acts as an apo-IDO1 inhibitor by slowly and competitively displacing heme from mature holo-IDO1 and rapidly binding to the heme-binding site of immature apo-IDO1, without altering the expression level of IDO1. IDO1-IN-33 can be used for the research of hepatocellular carcinoma, non-small cell lung cancer, triple-negative breast cancer, and cervical cancer .
loading...
    loading...
Cat. No.: HY-186120A
CAS No.: 73944-37-3
Research Areas:  

Cancer

N-(Aminoiminomethyl)-N-methyl-L-alanine is an Amino acid analog. N-(Aminoiminomethyl)-N-methyl-L-alanine can be used in cancer-related research .
loading...
    loading...
Cat. No.: HY-N21516
CAS No.: 1207265-02-8
Trigonostemon F is a modified euphorbia diterpenoid, which is found in the roots of Trigonostemon thyrsoideum and the stems of Trigonostemon howii. Trigonostemon F inhibits the proliferation of human tumor cell lines and the growth of specific bacteria in vitro. Trigonostemon F is applicable to cancer-related research .
loading...
    loading...
  • 1